BCAB - Bioatla - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Bioatla's activity chart (see below) currently has 34 price targets and 47 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.26% with an average time for these price targets to be met of 221.25 days.

Most recent stock forecast was given by from JMP on 09-Sep-2025. First documented stock forecast 11-Jan-2021.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Sep-2025

1 years 28 days ago
(09-Sep-2025)

3/8 (37.5%)

$0.65 (185.71%)

477

Hold Since 31-Mar-2025

1 years 6 months 6 days ago
(31-Mar-2025)

2/3 (66.67%)

$4 (133.33%)

710

Buy Since 03-Apr-2023

$17

3 years 12 days ago
(25-Sep-2023)

2/2 (100%)

$-132 (-88.59%)

633

Buy Since 28-Jun-2021

3 years 2 months 5 days ago
(02-Aug-2023)

0/2 (0%)

$846.5 (209.79%)

Buy Since 26-Mar-2021

$3400

3 years 6 months 9 days ago
(28-Mar-2023)

1/3 (33.33%)

$1982.5 (139.86%)

14

Show more analysts

Please expand the browser size to see the chart

What is BCAB (Bioatla) average time for price targets to be met?

On average it took 221 days for the stock forecasts to be reached, with an average price target met ratio of 42.26%.

Which analyst most recently updated their price target on BCAB (Bioatla)?

Which analyst has the most public recommendations on BCAB (Bioatla)?

has 0 price targets and 0 ratings on BCAB

Which analyst is the currently most bullish on BCAB (Bioatla)?

Anupam Rama with the highest potential upside of $2898.69

Which analyst is the currently most reserved on BCAB (Bioatla)?

Thomas Shrader with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?